Harvard Bioscience, Inc. (FRA:HBI)
0.6400
-0.0150 (-2.29%)
At close: Dec 19, 2025
Harvard Bioscience Market Cap
Harvard Bioscience has a market cap or net worth of €28.67 million as of December 22, 2025. Its market cap has decreased by -69.38% in one year.
Market Cap
28.67M
Enterprise Value
59.36M
Revenue
74.47M
Ranking
n/a
PE Ratio
n/a
Stock Price
€0.64
Market Cap Chart
Since December 7, 2000, Harvard Bioscience's market cap has decreased from 218.76M to 28.67M, a decrease of -86.90%. That is a compound annual growth rate of -7.79%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 19, 2025 | 28.67M | -67.75% |
| Dec 31, 2024 | 88.89M | -56.98% |
| Dec 29, 2023 | 206.62M | 91.36% |
| Dec 30, 2022 | 107.97M | -57.32% |
| Dec 31, 2021 | 252.99M | 85.08% |
| Dec 31, 2020 | 136.69M | 32.12% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| SAP SE | 243.93B |
| Siemens Aktiengesellschaft | 183.57B |
| Allianz SE | 146.73B |
| Deutsche Telekom AG | 130.04B |
| Siemens Energy AG | 102.30B |
| Rheinmetall AG | 71.12B |
| Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München | 70.51B |
| Deutsche Bank Aktiengesellschaft | 62.30B |